» Authors » Juan Carlos Martinez-Castrillo

Juan Carlos Martinez-Castrillo

Explore the profile of Juan Carlos Martinez-Castrillo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 673
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos-Garcia D, Lopez-Manzanares L, Muro I, Lorenzo-Barreto P, Casas Pena E, Garcia-Ramos R, et al.
Brain Sci . 2025 Jan; 14(12. PMID: 39766443
Background And Objective: Staging Parkinson's disease (PD) with a novel simple classification called MNCD, based on four axes (Motor; Non-motor; Cognition; Dependency) and five stages, correlated with disease severity, patients'...
2.
Freire-Alvarez E, Ramirez I, Garcia-Ramos R, Carrillo F, Santos-Garcia D, Gomez-Esteban J, et al.
Comput Biol Med . 2024 Dec; 185():109504. PMID: 39637457
Introduction: In Parkinson's Disease (PD), despite available treatments focusing on symptom alleviation, the effectiveness of conventional therapies decreases over time. This study aims to enhance the identification of candidates for...
3.
Santos-Garcia D, Lopez-Manzanares L, Muro I, Lorenzo-Barreto P, Casas Pena E, Garcia-Ramos R, et al.
Eur J Neurol . 2024 Oct; 32(1):e16535. PMID: 39466665
Background And Purpose: Levodopa-entacapone-carbidopa intestinal gel (LECIG) infusion is a recently developed device-aided therapy for advanced Parkinson disease (PD) patients. The aim of this study was to report real-world evidence...
4.
Delgado C, Lopez-Jimenez A, Lopez-Valdes E, Gomez-Mayordomo V, Baltasar-Corral A, Martinez-Castrillo J, et al.
Parkinsonism Relat Disord . 2023 Aug; 114:105776. PMID: 37544162
No abstract available.
5.
Gonzalez D, Bruna R, Martinez-Castrillo J, Lopez J, de Arcas G
Int J Neural Syst . 2023 Apr; 33(6):2350027. PMID: 37085963
This paper describes a longitudinal study to analyze the effects of acoustic stimulation with Binaural Beats (BBs) at 14[Formula: see text]Hz (beta band) in patients with Parkinson's Disease (PD). Participants...
6.
Alonso-Canovas A, Kurtis M, Gomez-Mayordomo V, Macias-Garcia D, Gutierrez Viedma A, Mondragon Rezola E, et al.
J Neurol Neurosurg Psychiatry . 2023 Mar; 94(9):776-777. PMID: 36889911
No abstract available.
7.
Sanchez Alonso P, De la Casa-Fages B, Alonso-Canovas A, Martinez-Castrillo J
Brain Sci . 2023 Feb; 13(2). PMID: 36831820
Parkinson's disease (PD) is a complex disease, and the treatment is focused on the patient's clinical symptoms. Levodopa continues to be the most effective drug for symptomatic PD treatment. However,...
8.
Manez-Miro J, Vivancos-Matellano F, Alonso-Frech F, Vela-Desojo L, Lopez-Ariztegui N, Lopez-Manzanares L, et al.
Mov Disord Clin Pract . 2022 Nov; 9(8):1085-1093. PMID: 36339297
Background: Dopamine replacement therapy reduces most motor and nonmotor features of Parkinson's disease. However, with disease progression, adjustments of dopaminergics and the application of advanced therapies must be considered. Objectives:...
9.
Sampedro F, Martinez-Horta S, Horta-Barba A, Grothe M, Labrador-Espinosa M, Jesus S, et al.
Eur J Neurol . 2022 Jul; 29(12):3720-3727. PMID: 35852918
Background And Purpose: Reduced facial expression of emotions is a very frequent symptom of Parkinson's disease (PD) and has been considered part of the motor features of the disease. However,...
10.
Perez-Lopez C, Hernandez-Vara J, Caballol N, Bayes A, Buongiorno M, Lopez-Ariztegui N, et al.
Front Neurol . 2022 Jun; 13:835249. PMID: 35651347
Background: For specialists in charge of Parkinson's disease (PD), one of the most time-consuming tasks of the consultations is the assessment of symptoms and motor fluctuations. This task is complex...